Mechanism for lowering blood ammonia levels by lactitol. 1995

M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., Kyoto, Japan.

Lactitol has been reported to decrease the blood ammonia concentration in various experimental hyperammonemia models such as portacaval shunted rats. The mechanism responsible for this lowering of blood ammonia levels was investigated in rats. When lactitol was given orally twice a day for 7 days at doses of 3 and 10 g/kg/day and at half that daily dose on day 8, it significantly decreased the ammonium concentration of the portal blood by 27.3-43.2%, cecal ammonia contents by 49.2-57.6% and the pH of the cecal contents from 6.52 to 5.92-5.54, 4 hr after the final administration. Lactitol also inhibited increases in the portal ammonia concentration induced by the intracecal administration of ammonium acetate (300 mg/kg) 4 hr after the final administration. When lactitol was given orally at bolus doses of 1 and 3 g/kg simultaneously with a charcoal meal, lactitol significantly facilitated small intestinal transit by 12-13%. At a bolus dose of 3 g/kg, given 1 hr before the administration of a charcoal meal into the proximal colon, lactitol significantly facilitated colonic transit by 29.5%. These effects of lactitol were similar to those of lactulose. These findings suggest that lactitol decreases blood ammonia concentration by inhibiting both the production and the absorption of ammonia through reducing intestinal pH and shortening the residence time of intestinal contents in the intestinal tract.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D007792 Lactulose A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887) Amivalex,Duphalac,Normase
D008297 Male Males
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D002432 Cecum The blind sac or outpouching area of the LARGE INTESTINE that is below the entrance of the SMALL INTESTINE. It has a worm-like extension, the vermiform APPENDIX. Cecums
D002606 Charcoal An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed) Activated Charcoal,Actidose,Actidose-Aqua,Adsorba,Carbomix,Charbon,CharcoAid,CharcoCaps,Charcodote,Formocarbine,Insta-Char,Kohle-Compretten,Kohle-Hevert,Kohle-Pulvis,Kohle-Tabletten Boxo-Pharm,Liqui-Char,Norit,Ultracarbon,Charcoal, Activated
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005772 Gastrointestinal Transit Passage of food (sometimes in the form of a test meal) through the gastrointestinal tract as measured in minutes or hours. The rate of passage through the intestine is an indicator of small bowel function. GI Transit,GI Transits,Gastrointestinal Transits,Transit, GI,Transit, Gastrointestinal,Transits, GI,Transits, Gastrointestinal

Related Publications

M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
November 1987, Lancet (London, England),
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
September 1987, Lancet (London, England),
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
November 1962, Archives of surgery (Chicago, Ill. : 1960),
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
January 1959, Anesthesie, analgesie, reanimation,
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
January 2015, International journal of clinical and experimental medicine,
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
April 2013, Medizinische Monatsschrift fur Pharmazeuten,
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
December 1958, Journal of the American Medical Association,
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
November 1956, The Journal of laboratory and clinical medicine,
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
December 2004, Metabolic brain disease,
M Watanabe, and T Ozaki, and Y Hirata, and O Yamamoto, and H Niida, and F Ueda, and Y Yoshikuni, and K Kimura
January 1957, Revista cubana de cardiologia,
Copied contents to your clipboard!